NEW stem cell treatment center in Valley helps with pain managementABC15 ArizonaBusiness Development Professionals Group is a paid advertiser of Sonoran Living. BDP Groups focuses on business development and Capital growth. We guide you through corpora… Continue reading
The Verge |
Scientists used human stem cells to build a new rat intestine
The Verge Scientists have built a new rat intestine by combining part of the animal’s own bowel with human stem cells. One day, this method could be used in humans with intestinal problems who currently have to rely on organ transplants. A variety of diseases, … Team creates functional, stem–cell-derived small bowel segmentsMedical Xpress Human intestines have been grown in a lab and transplanted into rats – paving the way to a cure for gut disordersDaily Mail |
Scientific American |
Gene Therapy for Blindness Appears Initially Effective, Says US FDA
Scientific American (Reuters) – Spark Therapeutics Inc’s experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration … Seeing hope: FDA panel considers gene therapy for blindnessABC News The FDA could soon approve gene therapy for blindnessThe Week Magazine With AdComm meeting looming, FDA shares concerns about Spark’s lead gene therapyFierceBiotech Press Herald –Endpoints News all 19 news articles » |
Simply Wall St |
Why CRISPR Therapeutics AG Stock Lost Ground in September
Motley Fool According to data from S&P Global Market Intelligence, shares of the gene-editing company CRISPR Therapeutics (NASDAQ:CRSP) dropped by 13.1% in September. CRISPR’s poor showing last month appears to stem from nothing more than investors … Next Capital Raising For CRISPR Therapeutics AG (CRSP)?Simply Wall St Street Analysts View On CRISPR Therapeutics AG (CRSP), China Life Insurance Company Limited (LFC)Post Analyst Crispr Therapeutics AG (CRSP) Expected to Announce Earnings of -$0.49 Per ShareBangaloreWeekly Highlight Press –Hot Stocks Point all 11 news articles » |
Cancer Therapy Advisor |
Arrival of CAR–T Immunotherapy Raise Hopes for Treatment and Anxieties About Costs
Cancer Therapy Advisor CAR-T therapies like CTL019 are “living drugs” produced by removing patients’ T cells through leukapheresis, a type of apheresis specific to white blood cells, for genetic modification at an offsite lab, amplification, and reinfusion into the patient. |